The convergence of
socioeconomic and technology factors – the
growing emphasis on drug self-administration for
chronic conditions, the expected acceleration in
protein- and peptide-based therapeutics, the
availability of innovative dry powder inhalation
devices with unique .......more
Advances in drug formulation and
inhalation device design are creating new opportunities for inhaled drug
delivery as an alternative to oral and parenteral delivery methods. Much
of the interest in pulmonary delivery of systemic drug therapies is
focused on chronic diseases and refractory conditions – aliments that
require .......more
Delivering drugs to the central nervous
system presents unique challenges. But, drug
developers and researchers have discovered that
delivering CNS therapeutic drugs via inhalation
mitigates several of these issues. The
accessibility and vascular structure of the nose
make it an attractive route for
delivering.........more
Copyright
2003-2008 Greystone Associates. All rights
reserved